Cargando…
Proteomic analysis identifies highly expressed plasma membrane proteins for detection and therapeutic targeting of specific breast cancer subtypes
In recent years, there has been an emphasis on personalizing breast cancer treatment in order to avoid the debilitating side effects caused by broad-spectrum chemotherapeutic drug treatment. Development of personalized medicine requires the identification of proteins that are expressed by individual...
Autores principales: | Ziegler, Yvonne S., Moresco, James J., Tu, Patricia G., Yates, John R., Nardulli, Ann M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145347/ https://www.ncbi.nlm.nih.gov/pubmed/30250408 http://dx.doi.org/10.1186/s12014-018-9206-0 |
Ejemplares similares
-
Plasma Membrane Proteomics of Human Breast Cancer Cell Lines Identifies Potential Targets for Breast Cancer Diagnosis and Treatment
por: Ziegler, Yvonne S., et al.
Publicado: (2014) -
Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis
por: Ziegler, Yvonne S., et al.
Publicado: (2016) -
Isolation of novel coregulatory protein networks associated with DNA-bound estrogen receptor alpha
por: Schultz-Norton, Jennifer R, et al.
Publicado: (2008) -
CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes
por: Avsar, Timucin, et al.
Publicado: (2015) -
Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancer
por: Collins, Kyla A.L., et al.
Publicado: (2018)